USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in Europe
Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in Europe
RELEASE DATE
24-Jan-2005
24-Jan-2005
REGION
Europe
Europe
Research Code: B483-01-00-00-00
SKU: HC01071-EU-MR_05105
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC01071-EU-MR_05105
Description
This Frost and Sullivan’s Strategic Analysis Service examines the status of pharmaceutical direct-to-consumer advertising in Europe. This service focuses on developments as well as provides general strategies.
Table of Contents
Introduction
- Introduction
- Overview
Direct-to-Consumer Advertising in Europe
- Pharmaceutical Direct-to-Consumer Advertising in Europe
- Challenges faced by DTC in Europe
- Key Market Drivers
- Benefits of DTCA to Patients and Pharmaceutical Companies
- Key Restraints
- Communication Chart
- DTCA and DTPA in Europe
Media
- DTC Advertising Media
- Media Expenditure
Competitive Landscape
- Regional Analysis
- DTCA Companies
Direct-to-Consumer Advertising Expenditure Forecasts and Analysis
- DTCA Expenditure Forecasts and Analysis
- Regional Analysis
- DTCA Expenditure Forecasts and Analysis for Europe
Strategic Analysis and Recommendations
- Strategic Analysis and Recommendations
Frost & Sullivan Awards
- Frost & Sullivan Awards
- Customer Service Leadership Award
- Brand Development Strategy Leadership Award
Decision Support Databases
- Decision Support Databases
Frost & Sullivan
- Our Team
- Consulting Capabilities
Popular Topics
This Frost and Sullivans Strategic Analysis Service examines the status of pharmaceutical direct-to-consumer advertising in Europe. This service focuses on developments as well as provides general strategies.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B483-01-00-00-00 |
| Is Prebook | No |